COMP <GO>
YDES vs FLGT // RETURN ON INVESTED CAPITAL (ROIC)
YD Bio Limited (NASDAQ) VS. Fulgent Genetics Inc. (NASDAQ) • 15-METRIC TALLY: YDES 4
— FLGT 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: FLGT
LAST: $5.87 (-6.53%) • MKT CAP: $415.8M
roic
-20.00%
LAST: $21.68 (+0.74%) • MKT CAP: $596.5M
roic
-6.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (YDES VS. FLGT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | YDES | FLGT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.10% | 40.60% | -12.50 | FLGT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -20.00% | -6.80% | -13.20 | FLGT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.93% | -20.82% | +18.89 | YDES | /fcf-yield <GO> |
| Operating Margin | -60.00% | -28.20% | -31.80 | FLGT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -18.80% | -41.20 | FLGT | /net-margins <GO> |
| Revenue Growth (YoY) | 16.90% | 13.80% | +3.10 | YDES | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 13.44 | 4.44 | +9.00 | YDES | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | YDES | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 56.3 | -4.60 | FLGT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $415.8M | $596.5M | -$180.8M | FLGT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | YDES REV | FLGT REV | YDES GROSS % | FLGT GROSS % | YDES FCF | FLGT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $596.8K | $322.7M | 28.1% | 40.6% | -$8.0M | -$124.2M |
| FY 2024 | $510.4K | $283.5M | 30.4% | 37.8% | -$1.3M | -$19.3M |
| FY 2023 | $350.1K | $289.2M | — | — | -$55.7K | $27.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
YDES // BETA —
FLGT // BETA —